SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $814 | -35.2% | 342,200 | +30.4% | 0.02% | -33.3% |
| Q2 2023 | $1,257 | -15.5% | 262,325 | 0.0% | 0.03% | -17.5% |
| Q1 2023 | $1,487 | +0.2% | 262,325 | -1.0% | 0.04% | -4.8% |
| Q4 2022 | $1,484 | -99.9% | 265,000 | +33.2% | 0.04% | +10.5% |
| Q3 2022 | $1,278,000 | +87.1% | 199,000 | 0.0% | 0.04% | +81.0% |
| Q2 2022 | $683,000 | +53.5% | 199,000 | +218.7% | 0.02% | +75.0% |
| Q1 2022 | $445,000 | -14.4% | 62,450 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $520,000 | +19.5% | 62,450 | 0.0% | 0.01% | +9.1% |
| Q3 2021 | $435,000 | -70.8% | 62,450 | 0.0% | 0.01% | -70.3% |
| Q2 2021 | $1,489,000 | – | 62,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |